PHENAZOPYRIDINE HYDROCHLORIDE TABLETS
- Manufacturer
- Drug Ocean LLC
- Effective date
- 2024-03-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 00:10:20
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Phenazopyridine Hydrochloride 99.5 mg
OTC - PURPOSE SECTION
Purpose
Urinary tract analgesic
INDICATIONS & USAGE SECTION
UseRelief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
WARNINGS SECTION
Warnings
Ask a doctor before use if you have
- kidney disease
- allergies to foods, preservatives or dyes
- had a hypersensitive reaction to Phenazopyridine Hydrochloride
OTC - DO NOT USE SECTION
Do not useif you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.
OTC - WHEN USING SECTION
When using this product
- stomach upset may occur, taking this product with or after meals may reduce stomach upset
- your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
OTC - STOP USE SECTION
Stop use and ask doctor if
- your symptoms last for more than 2 days
- you suspect you are having an adverse reaction to the medication.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breastfeeding,ask a healthcare professional before use. A pregnancy test and consultation with a healthcare professional if pregnancy is confirmed is recommended prior to use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.In case of an overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- Adults and children 12 years and older: Take 2 tablets 3 times daily with or after meals as needed for up to two days. Take with a full glass of water. Do not use for more than 2 days (12 tablets) without consulting a doctor.
- Children under 12: Do not use without consulting a doctor.
INACTIVE INGREDIENT SECTION
Inactive ingredients carnauba wax, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized corn starch. May also contain corn starch.
OTHER SAFETY INFORMATION
Other Information
- This product contains Phenazopyridine Hydrochloride, known to the State of California to cause cancer
- This product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
- This product may stain soft contact lenses and other items if handled after touching tablets
- Store at room temperature (59 o-86 oF) in a dry place and protect from light.
Tamper evident:Product is sealed within blisters. Do not use if any part of the blister is torn, open or damaged.
SPL UNCLASSIFIED SECTION
Questions or comments? Call 1-844-200-6566
Distributed by:
Drug Ocean LLC
1 Bridge Plaza, North Central Road,
6th Floor, Suite 675,
Fort Lee, NJ 07024
Made in India
Mfg License Code:
RA/Drug/RAJ.-1750
ORG 03/2024
Packaging
Drug Ocean NDC 70985- 029-09
Phenazopyridine Hydrochloride Tablets, 99.5 mg
Urinary Tract Pain Relief
- Relieves Pain, Burning and Urgency
- Targets the source of Pain
12 Tablets
Blister Label
Packaging
Drug Ocean NDC 70985- 029-13
Phenazopyridine Hydrochloride Tablets, 99.5 mg
Urinary Tract Pain Relief
- Relieves Pain, Burning and Urgency
- Targets the source of Pain
24 Tablets
Blister Label
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- PHENAZOPYRIDINE HYDROCHLORIDE
- MICROCRYSTALLINE CELLULOSE
- STARCH, CORN
- HYPROMELLOSE, UNSPECIFIED
- POVIDONE, UNSPECIFIED
- CROSCARMELLOSE SODIUM
- POLYETHYLENE GLYCOL, UNSPECIFIED
- CARNAUBA WAX
- MAGNESIUM STEARATE
- PHENAZOPYRIDINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70985-029 | 70985-029-09, 70985-029-13 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 429e35ba-df53-a5ce-e063-6394a90a6903 | a27b19a3-53e4-4887-bdf2-f1083ebff79d | 2025-11-02 | Warnings | a27b19a3-53e4-4887-bdf2-f1083ebff79d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



